184 related articles for article (PubMed ID: 20844001)
1. Tumor suppressor action of liganded thyroid hormone receptor beta by direct repression of beta-catenin gene expression.
Guigon CJ; Kim DW; Zhu X; Zhao L; Cheng SY
Endocrinology; 2010 Nov; 151(11):5528-36. PubMed ID: 20844001
[TBL] [Abstract][Full Text] [Related]
2. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
[TBL] [Abstract][Full Text] [Related]
3. Canonical Thyroid Hormone Receptor β Action Stimulates Hepatocyte Proliferation in Male Mice.
Hönes GS; Kerp H; Hoppe C; Kowalczyk M; Zwanziger D; Baba HA; Führer D; Moeller LC
Endocrinology; 2022 Mar; 163(3):. PubMed ID: 35038735
[TBL] [Abstract][Full Text] [Related]
4. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
Furumoto H; Ying H; Chandramouli GV; Zhao L; Walker RL; Meltzer PS; Willingham MC; Cheng SY
Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
[TBL] [Abstract][Full Text] [Related]
5. Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone: identification of a thyroid hormone response element in the murine Fgfr1 promoter.
O'Shea PJ; Guigon CJ; Williams GR; Cheng SY
Endocrinology; 2007 Dec; 148(12):5966-76. PubMed ID: 17761769
[TBL] [Abstract][Full Text] [Related]
6. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor.
Zhang XY; Kaneshige M; Kamiya Y; Kaneshige K; McPhie P; Cheng SY
Mol Endocrinol; 2002 Sep; 16(9):2077-92. PubMed ID: 12198244
[TBL] [Abstract][Full Text] [Related]
8. Nuclear corepressors mediate the repression of phospholipase A2 group IIa gene transcription by thyroid hormone.
Sharma P; Thakran S; Deng X; Elam MB; Park EA
J Biol Chem; 2013 Jun; 288(23):16321-16333. PubMed ID: 23629656
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
10. Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.
O'Shea PJ; Kim DW; Logan JG; Davis S; Walker RL; Meltzer PS; Cheng SY; Williams GR
J Biol Chem; 2012 May; 287(21):17812-17822. PubMed ID: 22442145
[TBL] [Abstract][Full Text] [Related]
11. 3, 3'5 Triiodo L thyronine induces apoptosis in human breast cancer MCF-7 cells, repressing SMP30 expression through negative thyroid response elements.
Sar P; Peter R; Rath B; Das Mohapatra A; Mishra SK
PLoS One; 2011; 6(6):e20861. PubMed ID: 21687737
[TBL] [Abstract][Full Text] [Related]
12. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
Park JW; Zhao L; Willingham MC; Cheng SY
Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation (E333D) in the thyroid hormone beta receptor causing resistance to thyroid hormone syndrome.
Maraninchi M; Bourcigaux N; Dace A; El-Yazidi C; Malezet-Desmoulins C; Krempf M; Torresani J; Margotat A
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):569-76. PubMed ID: 17177139
[TBL] [Abstract][Full Text] [Related]
14. Specific histone lysine 4 methylation patterns define TR-binding capacity and differentiate direct T3 responses.
Bilesimo P; Jolivet P; Alfama G; Buisine N; Le Mevel S; Havis E; Demeneix BA; Sachs LM
Mol Endocrinol; 2011 Feb; 25(2):225-37. PubMed ID: 21239616
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression.
Kim WG; Zhu X; Kim DW; Zhang L; Kebebew E; Cheng SY
Endocrinology; 2013 Jan; 154(1):25-35. PubMed ID: 23183175
[TBL] [Abstract][Full Text] [Related]
16. The targeted inactivation of TRβ gene in thyroid follicular cells suggests a new mechanism of regulation of thyroid hormone production.
Selmi-Ruby S; Bouazza L; Obregon MJ; Conscience A; Flamant F; Samarut J; Borson-Chazot F; Rousset B
Endocrinology; 2014 Feb; 155(2):635-46. PubMed ID: 24265449
[TBL] [Abstract][Full Text] [Related]
17. G ATA2 mediates the negative regulation of the prepro-thyrotropin-releasing hormone gene by liganded T3 receptor β2 in the rat hypothalamic paraventricular nucleus.
Kuroda G; Sasaki S; Matsushita A; Ohba K; Sakai Y; Shinkai S; Nakamura HM; Yamagishi S; Sato K; Hirahara N; Oki Y; Ito M; Suzuki T; Suda T
PLoS One; 2020; 15(11):e0242380. PubMed ID: 33201916
[TBL] [Abstract][Full Text] [Related]
18. Activation of the hepatic LDL receptor promoter by thyroid hormone.
Lopez D; Abisambra Socarrás JF; Bedi M; Ness GC
Biochim Biophys Acta; 2007 Sep; 1771(9):1216-25. PubMed ID: 17572141
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
Kim WG; Zhao L; Kim DW; Willingham MC; Cheng SY
Thyroid; 2014 Feb; 24(2):260-9. PubMed ID: 23731250
[TBL] [Abstract][Full Text] [Related]
20. Essential Role of GATA2 in the Negative Regulation of Type 2 Deiodinase Gene by Liganded Thyroid Hormone Receptor β2 in Thyrotroph.
Matsunaga H; Sasaki S; Suzuki S; Matsushita A; Nakamura H; Nakamura HM; Hirahara N; Kuroda G; Iwaki H; Ohba K; Morita H; Oki Y; Suda T
PLoS One; 2015; 10(11):e0142400. PubMed ID: 26571013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
